Clinical Trial Update: Prulifloxacin in Chronic Bacterial Prostatitis (CBP) [Phase 2]

View source ↗

Summary

Phase 2 trial update for prulifloxacin in chronic bacterial prostatitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Prostatitis

Drugs mentioned

• Prulifloxacin (Prulifloxacin)

Snippet

Sponsor: Aziende Chimiche Riunite Angelini Francesco S.p.A | Conditions: Chronic Bacterial Prostatitis | Phase 2 | Status: COMPLETED